Cargando…
INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971734/ https://www.ncbi.nlm.nih.gov/pubmed/35370498 http://dx.doi.org/10.1093/eurheartjsupp/suac007 |
| _version_ | 1784679696964780032 |
|---|---|
| author | Ferrari, Roberto |
| author_facet | Ferrari, Roberto |
| author_sort | Ferrari, Roberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8971734 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89717342022-04-01 INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs Ferrari, Roberto Eur Heart J Suppl INTERCARDIS Supplement Paper Oxford University Press 2022-03-30 /pmc/articles/PMC8971734/ /pubmed/35370498 http://dx.doi.org/10.1093/eurheartjsupp/suac007 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | INTERCARDIS Supplement Paper Ferrari, Roberto INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title | INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title_full | INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title_fullStr | INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title_full_unstemmed | INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title_short | INTERventional treatment for CARDIovaScular life-threatening diseases (Why is the INTERCARDIS an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| title_sort | interventional treatment for cardiovascular life-threatening diseases (why is the intercardis an important project for the cardiological community?): strategies for improving patient outcome and hospital costs |
| topic | INTERCARDIS Supplement Paper |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971734/ https://www.ncbi.nlm.nih.gov/pubmed/35370498 http://dx.doi.org/10.1093/eurheartjsupp/suac007 |
| work_keys_str_mv | AT ferrariroberto interventionaltreatmentforcardiovascularlifethreateningdiseaseswhyistheintercardisanimportantprojectforthecardiologicalcommunitystrategiesforimprovingpatientoutcomeandhospitalcosts |